
    
      This study aims to evaluate safety, immunogenicity, and transmission blocking activity of
      Pfs25IMX313-Matrix-M in healthy Tanzanian adults and children naturally exposed to malaria in
      Bagamoyo district, Tanzania. The study will enrol 45 volunteers comprising of 13 adults
      (18-45 years) and 32 children (5-12 years).
    
  